BioAegis Therapeutics website screenshot

BioAegis Therapeutics

BioAegis Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered at the NJ Bioscience Center in North Brunswick, New Jersey. Founded in 2011 around the discovery work of the late Dr. Thomas P. Stossel at Harvard Medical School and Brigham and Women's Hospital, the company develops recombinant human plasma gelsolin (rhu-pGSN) — a protein replacement therapy built on plasma gelsolin (pGSN), an abundant naturally occurring human blood protein that acts as a master regulator of the innate immune response by keeping inflammation localized to the site of injury and boosting the body's ability to clear pathogens. Its lead programme, BTI-203, is a 600-patient, 75-site, 13-country randomized double-blind placebo-controlled Phase 2 study of rhu-pGSN in moderate-to-severe acute respiratory distress syndrome (ARDS), supported by a $20M BARDA DRIVe contract (75A50123C00067); a second Phase 2 programme targets inflammasome-driven decompression sickness under a U.S. Navy Office of Naval Research contract with the University of Maryland School of Medicine. The FDA has granted Fast Track designation for both ARDS and DCS indications. BioAegis holds an exclusive worldwide license from Brigham and Women's Hospital and more than 40 issued patents spanning inflammatory disease, infection, renal failure, neurologic disease and frailty. BioAegis Therapeutics runs no developer program and publishes no product API, developer portal or API documentation. The only machine-readable surface reachable without credentials is the WordPress REST content API behind www.bioaegistherapeutics.com, catalogued here.

BioAegis Therapeutics publishes 10 APIs on the APIs.io network, including Blocks API, Comments API, Discovery API, and 7 more. Tagged areas include Company, biopharmaceuticals, biotechnology, clinical-trials, and immunology.

The BioAegis Therapeutics catalog on APIs.io includes 1 JSON-LD context.

BioAegis Therapeutics’ developer surface includes FAQ, product news, support, YouTube channel, authentication, and 28 more developer resources.

🌐 Visit website 📡 Source on GitHub
32.0/100 thin ▬ flat Agent 30/100 agent aware Full breakdown ↓
scored 2026-08-12 · rubric v0.11.0
10 APIs
Companybiopharmaceuticalsbiotechnologyclinical-trialsimmunologyinflammationinnate-immunitygelsolinprotein-therapeuticsardscritical-carerare-diseasedrug-developmentlife-sciencescontent-api

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-12 · rubric v0.11.0
Composite quality — 32.0/100 · thin
Contract Quality 12.8 / 21
Developer Ergonomics 2.9 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 1.2 / 10
Discoverability 6.9 / 9
Regulatory Posture 4.7 / 15
Agent readiness — 30/100 · agent aware
Machine-Readable Contract 18 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 10 / 10
Idempotency 0 / 9
Stable Error Semantics 8 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 5 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/bioaegis-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

APIs 10

Individual APIs this provider publishes, each with its own machine-readable definition.

BioAegis Therapeutics Blocks API

Reusable block patterns and navigation menus. Both registered and reachable, but empty (X-WP-Total 0) — the site is built with Elementor, not the block editor.

BioAegis Therapeutics Comments API

Comment collection. Registered and reachable, but empty (X-WP-Total 0).

BioAegis Therapeutics Discovery API

Route, type, taxonomy and status discovery documents.

BioAegis Therapeutics Media API

Media library — 247 attachments at harvest time.

BioAegis Therapeutics Oembed API

oEmbed 1.0 provider endpoint for bioaegistherapeutics.com URLs.

BioAegis Therapeutics Pages API

Corporate pages — 14 published at harvest time (Home, About Us, Our Science, Our Platform, BTI-203 Clinical Trial, FAQs, Publications, News, Careers, Contact Us, Expanded Access...

BioAegis Therapeutics Posts API

Post collection — 153 published items at harvest time, spanning News press releases (94), Publications (34), Events (9), Clinical advisory board profiles (6), Leadership profile...

BioAegis Therapeutics Search API

Cross-content search across published posts and pages.

BioAegis Therapeutics Seo API

Yoast SEO head-tag rendering for a bioaegistherapeutics.com URL — the only anonymously readable operation in the yoast/v1 namespace, and the carrier of the site's schema.org JSO...

BioAegis Therapeutics Taxonomy API

Categories and tags. The hierarchical `category` taxonomy holds 10 terms and carries all classification; the flat `post_tag` taxonomy is registered but empty (0 terms).

Scroll for all 10

Semantic Vocabularies 1

JSON-LD contexts and semantic vocabularies used across these APIs.

Bioaegis Therapeutics Organization Context

0 classes · 0 properties

JSON-LD

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Bioaegis Therapeutics Authentication

1 scheme

SECURITY

Bioaegis Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

ClinicalTrial
ClinicalTrial

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

WellKnown
WellKnown
 LLMsTxt
LLMsTxt
 AgentSkill
AgentSkill

Design & Contract 6

Pagination, idempotency, versioning, errors, and events

Conventions
Conventions
 Conformance
Conformance
 ErrorCatalog
ErrorCatalog
 Lifecycle
Lifecycle
 DataModel
DataModel
 JSONLD
JSONLD

Build 1

SDKs, sample code, and the tooling you integrate with

CodeOfConduct
CodeOfConduct

Access & Security 2

Authentication, authorization, and security posture

Authentication
Authentication
 DomainSecurity
DomainSecurity

Learn 1

Tutorials, courses, talks, and written guidance

YouTube
YouTube

Operate 3

Status, limits, changes, and where to get help

FAQ
FAQ
 Contact
Contact
 Support
Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService
TermsOfService
 PrivacyPolicy
PrivacyPolicy

Company 7

The organization behind the API

Website
Website
 About
About
 News
News
 BlogRSS
BlogRSS
 Careers
Careers
 LinkedIn
LinkedIn
 Twitter
Twitter

Scroll for all 7

Other 7

Properties that don't map to a standard resource type

Overlay
Overlay
 Science
Science
 Platform
Platform
 Publications
Publications
 ExpandedAccess
ExpandedAccess
 Sitemap
Sitemap
 SecondaryMarket
SecondaryMarket

Scroll for all 7

Source (apis.yml)

apis.yml Raw ↑ 
aid: bioaegis-therapeutics
name: BioAegis Therapeutics
description: BioAegis Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered at the
  NJ Bioscience Center in North Brunswick, New Jersey. Founded in 2011 around the discovery work of the late Dr. Thomas P.
  Stossel at Harvard Medical School and Brigham and Women's Hospital, the company develops recombinant human plasma gelsolin
  (rhu-pGSN) — a protein replacement therapy built on plasma gelsolin (pGSN), an abundant naturally occurring human blood
  protein that acts as a master regulator of the innate immune response by keeping inflammation localized to the site of injury
  and boosting the body's ability to clear pathogens. Its lead programme, BTI-203, is a 600-patient, 75-site, 13-country randomized
  double-blind placebo-controlled Phase 2 study of rhu-pGSN in moderate-to-severe acute respiratory distress syndrome (ARDS),
  supported by a $20M BARDA DRIVe contract (75A50123C00067); a second Phase 2 programme targets inflammasome-driven decompression
  sickness under a U.S. Navy Office of Naval Research contract with the University of Maryland School of Medicine. The FDA
  has granted Fast Track designation for both ARDS and DCS indications. BioAegis holds an exclusive worldwide license from
  Brigham and Women's Hospital and more than 40 issued patents spanning inflammatory disease, infection, renal failure, neurologic
  disease and frailty. BioAegis Therapeutics runs no developer program and publishes no product API, developer portal or API
  documentation. The only machine-readable surface reachable without credentials is the WordPress REST content API behind
  www.bioaegistherapeutics.com, catalogued here.
image: https://www.bioaegistherapeutics.com/wp-content/uploads/2020/08/cropped-BioAegis_Basics_white_therapeutics_scaled_with_trademark.webp
url: https://raw.githubusercontent.com/api-evangelist/bioaegis-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-07'
modified: '2026-08-07'
tags:
- Company
- biopharmaceuticals
- biotechnology
- clinical-trials
- immunology
- inflammation
- innate-immunity
- gelsolin
- protein-therapeutics
- ards
- critical-care
- rare-disease
- drug-development
- life-sciences
- content-api
apis:
- aid: bioaegis-therapeutics:bioaegis-therapeutics-blocks-api
  name: BioAegis Therapeutics Blocks API
  description: Reusable block patterns and navigation menus. Both registered and reachable, but empty (X-WP-Total 0) — the
    site is built with Elementor, not the block editor.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - blocks
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-blocks-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-comments-api
  name: BioAegis Therapeutics Comments API
  description: Comment collection. Registered and reachable, but empty (X-WP-Total 0).
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - comments
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-comments-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-discovery-api
  name: BioAegis Therapeutics Discovery API
  description: Route, type, taxonomy and status discovery documents.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - discovery
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-discovery-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-media-api
  name: BioAegis Therapeutics Media API
  description: Media library — 247 attachments at harvest time.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - media
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-media-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-oembed-api
  name: BioAegis Therapeutics Oembed API
  description: oEmbed 1.0 provider endpoint for bioaegistherapeutics.com URLs.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - oembed
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-oembed-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-pages-api
  name: BioAegis Therapeutics Pages API
  description: Corporate pages — 14 published at harvest time (Home, About Us, Our Science, Our Platform, BTI-203 Clinical
    Trial, FAQs, Publications, News, Careers, Contact Us, Expanded Access Policy, Code of Ethics/Conduct, Terms of Use, Privacy
    Policy).
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - pages
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-pages-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-posts-api
  name: BioAegis Therapeutics Posts API
  description: Post collection — 153 published items at harvest time, spanning News press releases (94), Publications (34),
    Events (9), Clinical advisory board profiles (6), Leadership profiles (5), Board profiles (4), Feature entries (2) and
    COVID19 (1).
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - posts
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-posts-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-search-api
  name: BioAegis Therapeutics Search API
  description: Cross-content search across published posts and pages.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - search
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-search-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-seo-api
  name: BioAegis Therapeutics Seo API
  description: Yoast SEO head-tag rendering for a bioaegistherapeutics.com URL — the only anonymously readable operation in
    the yoast/v1 namespace, and the carrier of the site's schema.org JSON-LD graph.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - seo
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-seo-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
- aid: bioaegis-therapeutics:bioaegis-therapeutics-taxonomy-api
  name: BioAegis Therapeutics Taxonomy API
  description: Categories and tags. The hierarchical `category` taxonomy holds 10 terms and carries all classification; the
    flat `post_tag` taxonomy is registered but empty (0 terms).
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - taxonomy
  properties:
  - type: OpenAPI
    url: openapi/bioaegis-therapeutics-taxonomy-api-openapi.yml
  - type: Authentication
    url: authentication/bioaegis-therapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/bioaegis-therapeutics-problem-types.yml
  - type: Conventions
    url: conventions/bioaegis-therapeutics-conventions.yml
  - type: DataModel
    url: data-model/bioaegis-therapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/bioaegis-therapeutics-json-ld.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/bioaegis-therapeutics-content-overlay.yaml
- type: Website
  url: https://www.bioaegistherapeutics.com/
- type: About
  url: https://www.bioaegistherapeutics.com/about-us/
- type: Science
  url: https://www.bioaegistherapeutics.com/our-science/
- type: Platform
  url: https://www.bioaegistherapeutics.com/our-platform/
- type: ClinicalTrial
  url: https://www.bioaegistherapeutics.com/bti-203-clinical-trial/
- type: Publications
  url: https://www.bioaegistherapeutics.com/publications-plasma-gelsolin/
- type: FAQ
  url: https://www.bioaegistherapeutics.com/faqs/
- type: News
  url: https://www.bioaegistherapeutics.com/news-plasma-gelsolin/
- type: BlogRSS
  url: https://www.bioaegistherapeutics.com/feed/
- type: Careers
  url: https://www.bioaegistherapeutics.com/careers/
- type: Contact
  url: https://www.bioaegistherapeutics.com/contact-us/
- type: Support
  url: https://www.bioaegistherapeutics.com/contact-us/
- type: ExpandedAccess
  url: https://www.bioaegistherapeutics.com/expanded-access-policy/
- type: CodeOfConduct
  url: https://www.bioaegistherapeutics.com/code-of-ethics-conduct/
- type: TermsOfService
  url: https://www.bioaegistherapeutics.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.bioaegistherapeutics.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/bioaegis-therapeutics
- type: Twitter
  url: https://twitter.com/bioaegis
- type: YouTube
  url: https://www.youtube.com/channel/UC9AflH4d_CL1TZLTBwb21HA
- type: Sitemap
  url: https://www.bioaegistherapeutics.com/sitemap_index.xml
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/
- type: Authentication
  url: authentication/bioaegis-therapeutics-authentication.yml
- type: Conventions
  url: conventions/bioaegis-therapeutics-conventions.yml
- type: Conformance
  url: conformance/bioaegis-therapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/bioaegis-therapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/bioaegis-therapeutics-lifecycle.yml
- type: DataModel
  url: data-model/bioaegis-therapeutics-data-model.yml
- type: JSONLD
  url: json-ld/bioaegis-therapeutics-json-ld.yml
- type: WellKnown
  url: well-known/bioaegis-therapeutics-well-known.yml
- type: DomainSecurity
  url: security/bioaegis-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/bioaegis-therapeutics-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-07'
  status: enriched
  artifacts_added: 17
  pass: local-v1